Asia Focus Of Global Drug Makers Seeking Local-Disease Treatments
This article was originally published in PharmAsia News
Asia's emerging markets are seeing more of Western drug makers seeking to take advantage of a need for diseases almost unique to the region. U.S.-based companies are at the forefront of the new move
You may also be interested in...
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.